History of myeloid-derived suppressor cells
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Myeloid-derived suppressor cells (MDSCs), a heterogeneous group of immune cells from the myeloid lineage, are a major component of the immunosuppressive TME [93].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
The cited source says what the claim attributes to it.
In the citing paper
“The TME is immunosuppressive, thus rendering the immune system less effective in killing cancer cells.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Goycoolea, A. (1997) · Cited by 3,615
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Research works printed but not linked: 1
- Sonnenfeld A Leukamische reaktiones bei carcinoma Zeitschrift f Klin Med 1929 111
Cited by
Items 701–800 of 1,000
Novel CD11b + Gr-1 + Sca-1 + myeloid cells drive mortality in bacterial infection
Park, M. Y., Kim, H. S., Lee, H. Y., Zabel, B. A., & Bae, Y. (2020) · Science Advances · doi:10.1126/sciadv.aax8820 · Cited by 18
Chen, J., Chen, Y., Jiang, N., Xu, J., Liang, Z., Bai, M., Xing, Y., Liu, Z., Wu, X.-Y., & Li, X. (2021) · The Oncologist · doi:10.1002/onco.13743 · Cited by 18
Innate Lymphoid Cells: Role in Immune Regulation and Cancer
Chung, D. C., Jacquelot, N., Ghaedi, M., Warner, K., & Ohashi, P. S. (2022) · Cancers · doi:10.3390/cancers14092071 · Cited by 18
Myeloid-derived suppressor cells and vaccination against pathogens
Prochetto, E., Borgna, E., Jiménez‐Cortegana, C., Sánchez‐Margalet, V., & Cabrera, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1003781 · Cited by 19
Fernández, A., Oliver, L., Álvarez-Arzola, R., Hernández, A., Raymond, J., Fernandez, L. E., & Mesa, C. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-5 · Cited by 20
Tanrιöver, G., Eyinç, M. B., Aliyev, E., Dilmaç, S., & Erin, N. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.03.013 · Cited by 18
Álvarez-Arzola, R., Oliver, L., Valdés, A. F.-C., & Mesa, C. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.05.001 · Cited by 18
Lattanzi, C., Bianchetto-Aguilera, F. M., Donini, M., Pettinella, F., Caveggion, E., Castellucci, M., Gasperini, S., Mariotti, B., Signoretto, I., Cantini, M., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2521396 · Cited by 17
Sun, Y., Mo, Y., Jiang, S., Shang, C., Feng, Y., & Zeng, X. (2022) · Cancer Science · doi:10.1111/cas.15598 · Cited by 17
Gulia, S., Chandra, P., & Das, A. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01179-4 · Cited by 17
Nitric Oxide: Regulation and Function in Neutrophil Immune Responses
Kumar, S., & Dikshit, M. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0220 · Cited by 17
Wan, Y., Mu, X., Zhao, J., Li, L., Xu, W., & Zhang, M. (2024) · Biomedical Reports · doi:10.3892/br.2024.1754 · Cited by 18
Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium
Tentori, C. A., Zhao, L., Tinterri, B., Strange, K. E., Zoldan, K., Dimopoulos, K., Feng, X., Riva, E., Lim, B., Simoni, Y., et al. (2024) · HemaSphere · doi:10.1002/hem3.64 · Cited by 17
Tian, T., Wang, J., Wang, W., Wu, H., Li, Q., Wang, F., Wang, H., & Zha, Z. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202403118 · Cited by 17
Jiménez‐Cortegana, C., Gutiérrez‐García, C., Sánchez-Jiménez, F., Vilariño‐García, T., Flores-Campos, R., Pérez‐Pérez, A., Garnacho, C., Sánchez‐León, M., García-Domínguez, D. J., Hontecillas‐Prieto, L., et al. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5667 · Cited by 17
Wang, Y., Li, S., & Wang, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1436174 · Cited by 20
Xiong, D., Geng, H., Lv, X., Wang, S., & Jia, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s504694 · Cited by 17
Sun, F., Gao, X., Li, T., Zhao, X., & Zhu, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189350 · Cited by 17
Manipulation of Innate Immunity for Cancer Therapy in Dogs
Regan, D. P., & DOW, S. W. (2015) · Veterinary Sciences · doi:10.3390/vetsci2040423 · Cited by 19
Raber, P. L., Sierra, R. A., Thevenot, P., Shuzhong, Z., Wyczechowska, D. D., Kumai, T., Celis, E., & Rodríguez, P. C. (2016) · Oncotarget · doi:10.18632/oncotarget.8197 · Cited by 18
Interleukin‑12 exacerbates Sj�gren's syndrome through induction of myeloid‑derived suppressor cells
Qi, J., Li, D., Shi, G., Zhang, B., Pan, Y., Dou, H., Wang, T., Yao, G., & Hou, Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10352 · Cited by 18
The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression
Hwang, B.-J., Zhang, Y., Brozowski, J. M., Liu, Z., Burette, S., Lough, K. J., Smith, C. C., Shan, Y., Chen, J., Li, N., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0961-9 · Cited by 18
Chen, L., Xiong, L., Hong, S., Li, J., Huo, Z., Li, Y., Chen, S., Zhang, Q., Zhao, R., Gingold, J. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa344 · Cited by 18
Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
Papafragkos, I., Markaki, E., Kalpadakis, C. H., & Verginis, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163462 · Cited by 18
Diverse roles of tumor-stromal PDGFB-to-PDGFRβ signaling in breast cancer growth and metastasis
Shah, S., & Sizemore, G. M. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.01.003 · Cited by 19
Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer
Chen, L., & Deng, J. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02264-6 · Cited by 17
Senescence and Cancer: In the Name of Immunosuppression
Llanos, S., & Serrano, M. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.015 · Cited by 17
Gao, Q., Jiang, J., Chu, Z., Lin, H., Zhou, X., & Liang, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.5679 · Cited by 17
Tajbakhsh, A., Farahani, N., Gheibihayat, S. M., Mirkhabbaz, A. M., Savardashtaki, A., Hamblin, M. R., & Mirzaei, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107177 · Cited by 17
GM-CSF Nitration Is a New Driver of Myeloid Suppressor Cell Activity in Tumors
Calì, B., Agnellini, A. H. R., Cioccarelli, C., Sánchez‐Rodríguez, R., Predonzani, A., Toffolo, G. I., Viola, A., Bronte, V., Arrigoni, G., Zonta, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718098 · Cited by 16
Zhao, Y., Lv, B., Xue, G., Sun, Y., & Cao, J. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s413204 · Cited by 16
O’Connor, M. A., Vella, J. L., & Green, W. R. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000260 · Cited by 16
Immunogenic FEAT protein circulates in the bloodstream of cancer patients
Li, Y., KOBAYASHI, K., Mona, M. M., Satomi, C., Okano, S., Inoue, H., Tani, K., & Takahashi, A. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1034-2 · Cited by 16
Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses
Hillman, G. G. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.002 · Cited by 16
Moss, J. W. E., Williams, J. O., Al‐Ahmadi, W., O’Morain, V. L., Chan, Y., Hughes, T. R., Menendez-Gonzalez, J. B., Almotiri, A., Plummer, S. F., Rodrigues, N. P., et al. (2021) · Food & Function · doi:10.1039/d0fo02867c · Cited by 16
Lu, Y., Xiao, Y., Yin, M., Zhou, X., Wu, L., Chen, W., Luo, Y., Kuang, Y., & Zhu, W. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.560579 · Cited by 16
Liu, P., Peng, C., Chen, X., Wu, L., Yin, M., Li, J., Qin, Q., Kuang, Y., & Zhu, W. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.625130 · Cited by 19
Myelopoiesis during Solid Cancers and Strategies for Immunotherapy
Wildes, T. J., Dean, B. D., & Flores, C. T. (2021) · Cells · doi:10.3390/cells10050968 · Cited by 17
Emerging Roles of Long Noncoding RNAs in Immuno-Oncology
Wang, X., Wang, X., Xu, M., & Sheng, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722904 · Cited by 16
Wen, J., Xuan, B., Gao, Y., Liu, Y., Wang, L., He, L., Xiangcai, M., Zhou, T., Tao, Y., Guo, K., et al. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104676 · Cited by 16
Li, Y., Qiao, K., Zhang, X., Liu, H., Zhang, H., Li, Z., Liu, Y., & Sun, T. (2021) · iScience · doi:10.1016/j.isci.2021.103392 · Cited by 16
Innate Immune Pathways Associated with Lung Radioprotection by Soy Isoflavones
Close, L. A., Fountain, M. D., Joiner, M. C., & Hillman, G. G. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00007 · Cited by 16
Li, S., Wang, N., Tan, H., Hong, M., Yuen, M., Li, H., & Feng, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01524 · Cited by 16
Cancer evolution: Special focus on the immune aspect of cancer
Hu, X., Chen, Z., Wang, Z., & Xiao, Q. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.006 · Cited by 15
c-Rel-dependent monocytes are potent immune suppressor cells in cancer
Li, T., Bou-Dargham, M. J., Fultang, N., Li, X., Pear, W. S., Sun, H., & Chen, Y. H. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ma0422-518rr · Cited by 15
Current status and future of cancer vaccines: A bibliographic study
Yu, R., Zhao, F., Xu, Z., Zhang, G., Du, B., & Shu, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24404 · Cited by 16
Zhou, J., Xu, H. M., Li, X., Liu, H., Sun, Z., Li, J., Tang, Y., Gao, H., Zhao, K., Ding, C., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107204 · Cited by 15
Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways
Zhang, Y. L., Guo, N., Zhu, H., Liu, M., Hao, J., Wang, S., Guo, T., Mamun, M., Pang, J., Liu, Q., et al. (2024) · Theranostics · doi:10.7150/thno.102037 · Cited by 15
Jing, X., Sonoki, T., Miyajima, M., Sawada, T., Terada, N., Takemura, S., & Sakaguchi, K. (2016) · Cancer Medicine · doi:10.1002/cam4.670 · Cited by 15
Myeloid‐Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?
Su, Z., Ni, P., Zhou, C., & Wang, J. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12473 · Cited by 15
Xu, J., Peng, Y., Yang, M., Guo, N., Liu, H., Gao, H., Niu, F., Wang, R., Wang, C., & Yu, K. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109864 · Cited by 16
Biomimetic phototherapy in cancer treatment: from synthesis to application
Zhao, Y., Shi, C., & Cao, J. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1983082 · Cited by 15
Capitani, N., Patrussi, L., & Baldari, C. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011221 · Cited by 16
Bizymi, N., Georgopoulou, Α., Mastrogamvraki, N., Matheakakis, A., Gontika, I., Fragiadaki, I., Mavroudi, I., & Papadaki, H. Α. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030727 · Cited by 15
Co-dependencies in the tumor immune microenvironment
Chen, P., & Dey, P. (2022) · Oncogene · doi:10.1038/s41388-022-02406-7 · Cited by 15
Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist
Johansen, P. T., Zucker, D., Parhamifar, L., Pourhassan, H., Madsen, D. V., Henriksen, J. R., Gad, M., Barberis, A., Maj, R., Andresen, T. L., et al. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1009444 · Cited by 15
Greten, T. F. (2014) · Gut · doi:10.1136/gutjnl-2014-306790 · Cited by 15
Expanding the List of Dysregulated Immunosuppressive Cells in Psoriasis
Soler, D. C., & McCormick, T. S. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.04.029 · Cited by 15
Kamioka, Y., Takakura, K., Sumiyama, K., & Matsuda, M. (2016) · Cancer Science · doi:10.1111/cas.13132 · Cited by 15
Abedi‐Valugerdi, M., Zheng, W., Benkessou, F., Zhao, Y. H., & Hassan, M. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.04.006 · Cited by 15
Chen, S., Yang, L., Dong, H. F., & Guo, H. Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108700 · Cited by 15
Identification of key genes in osteosarcoma by meta‑analysis of gene expression microarray
Sun, J., Xu, H., Qi, M., Zhang, C., & Shi, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10543 · Cited by 15
Ou, X., & Lv, W. (2020) · Future Oncology · doi:10.2217/fon-2019-0692 · Cited by 15
Yang, P., Ding, J., Bian, Y., Ma, Z., Wang, K., & Li, J. (2022) · Medical Oncology · doi:10.1007/s12032-022-01680-5 · Cited by 16
Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
Kauppinen, A., Kaarniranta, K., & Salminen, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00384 · Cited by 15
Pediatric gliomas immunity challenges and immunotherapy advances
Vetsika, E., Katsianou, M. A., Sarantis, P., Palamaris, K., Papavassiliou, A. G., & Piperi, C. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217640 · Cited by 14
MDSCs in pregnancy and pregnancy-related complications: an update
Shah, N. K., Xu, P., Shan, Y., Chen, C., Xie, M., Li, Y., Meng, Y., Shu, C., Dong, S., & He, J. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac213 · Cited by 15
Gao, F., You, X., Yang, L., Zou, X., & Sui, B. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2333275 · Cited by 15
Kong, J., Sai, H., Crissey, M. A. S., Jhala, N. C., Falk, G. W., Ginsberg, G. G., Abrams, J. A., Nakagawa, H., Wang, K., Rustgi, A. K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5431 · Cited by 14
Establishment of lal-/- Myeloid Lineage Cell Line That Resembles Myeloid-Derived Suppressive Cells
Ding, X., Wu, L., Yan, C., & Du, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121001 · Cited by 14
The Role of ERO1? in Modulati ng Cancer Progression and Immune Escape
Johnson, B. D., Geldenhuys, W. J., & Hazlehurst, L. (2020) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.2.023 · Cited by 26
Chen, S., Huang, F., He, C., Li, J., Chen, S., Li, Y., Chen, Y., Lian, G., & Huang, K. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-980 · Cited by 14
Xu, W., Li, S., Li, M., Yang, X., Xie, S.-J., Lin, L., Li, G., & Zhou, H. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.09.011 · Cited by 16
Lin, F.-Y., Chen, H., Jiang, T., Zheng, J., Liu, Q., Yang, B., Wang, X., & Lin, X. (2022) · Immunotherapy · doi:10.2217/imt-2021-0018 · Cited by 16
Tran, T., Lavillegrand, J., Lerévérend, C., Esposito, B., Cartier, L., Montabord, M., Tran-Rajau, J., Diedisheim, M., Gruel, N., Ouguerram, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33034-0 · Cited by 16
The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
Dong, P., Yan, Y., Fan, Y., Wang, H., Wu, D., Yang, L., Zhang, J., Yin, X., Lv, Y., Zhang, J., et al. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221142472 · Cited by 15
Myeloid-derived suppressor cells in head and neck squamous cell carcinoma
He, J.-Y., Huo, F., Tang, H., Liu, B., & Bu, L. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2022.11.002 · Cited by 15
Porrata, K. A. L. F. (2011) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s3-005 · Cited by 15
Targeting KIT on Innate Immune Cells to Enhance the Antitumor Activity of Checkpoint Inhibitors
Stahl, M. F., Gedrich, R. W., Peck, R., LaVallee, T. M., & Eder, J. P. (2016) · Immunotherapy · doi:10.2217/imt-2016-0040 · Cited by 14
Zhang, H., He, G., Kong, Y., Chen, Y., Wang, B., Sun, X., Jia, B., Xie, X., Wang, X., Chen, D., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12917 · Cited by 14
Anti-inflammatory role of CD11b+Ly6G+ neutrophilic cells in allergic airway inflammation in mice
Nowroozilarki, N., Öz, H. H., Schroth, C., Hector, A., Nürnberg, B., Hartl, D., & Kolahian, S. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.10.007 · Cited by 14
Fatty Acid Mediators in the Tumor Microenvironment
Khadge, S., Sharp, J. G., Thiele, G. M., McGuire, T. R., & Talmadge, J. E. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_8 · Cited by 14
Self-citationEngineered drug-loaded cells and cell derivatives as a delivery platform for cancer immunotherapy
Wang, L., & Liu, J. (2020) · Biomaterials Science · doi:10.1039/d0bm01676d · Cited by 14
Dai, H., Wu, Z., Jia, H., Tong, C., Guo, Y., Ti, D., Han, X., Liu, Y., Zhang, W., Wang, C., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00878-2 · Cited by 14
“Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach“
Li, X., & Song, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646292 · Cited by 13
Bao, W., Qu, X., Wang, Y., Huang, D., Zhang, H., Dong, M., Sun, H., Yang, Z., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70599 · Cited by 15
Single‐cell transcriptomics dissects premalignant progression in proliferative verrucous leukoplakia
Zhong, L., Wang, F., Liu, D., Kuang, W., Ji, N., Li, J., Zeng, X. Y., Li, T., Dan, H., & Chen, Q. (2022) · Oral Diseases · doi:10.1111/odi.14347 · Cited by 13
Long, Q., Yang, Y., Liao, F., Chen, H., He, D., Li, S., Li, P., Guo, W., & Xiao, Y. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00711a · Cited by 13
Kansy, B., Wehrs, T. P., Bruderek, K., Si, Y., Ludwig, S., Droege, F., Haßkamp, P., Henkel, U., Dominas, N., Hoffmann, T. K., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03571-8 · Cited by 13
Lu, Z., Wang, X., Feng, J., Chai, W., Wang, W., Wang, Q., Shen, Y., Yang, W. P., Su, Y., Mou, W., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1363454 · Cited by 13
Targeting the adenosine signaling pathway in macrophages for cancer immunotherapy
Han, Y., Zhang, Z., Zhao, K., Zhang, Y., Yin, X., Zhu, G., Wang, Z., Yan, X., Li, X., He, T., et al. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.110774 · Cited by 14
Ferroptosis contributes to immunosuppression
He, N., Yuan, D., Luo, M., Xu, Q., Wen, Z., Wang, Z., Zhao, J., & Liu, Y. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1080-8 · Cited by 13
Owen, D. H., Benner, B. N., Pilcher, C., Good, L., Savardekar, H., Norman, R., Ghattas, C., Shah, M. H., Konda, B., Verschraegen, C. F., et al. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.10.018 · Cited by 13
Xing, Y., Cai, J., Qin, J.-J., Zhou, W., Li, C., & Li, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577253 · Cited by 13
Nagatani, Y., Funakoshi, Y., Suto, H., Imamura, Y., Toyoda, M., Kiyota, N., Yamashita, K., & Minami, H. (2021) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1222_20 · Cited by 15
ICU and Sepsis: Role of Myeloid and Lymphocyte Immune Cells
Wang, A., Zhang, S., Peng, G., Tang, Y., & Yang, Y. (2022) · Journal of Oncology · doi:10.1155/2022/7340266 · Cited by 13
Zhou, L., Lin, X., Zhang, L., Chen, S., Chen, J., Zhou, Z., Tang, A., Ruan, J., Wang, X., & Chen, B. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109329 · Cited by 13
Myeloid-derived suppressor cells: A new emerging player in endometriosis
Zhang, T., He, Y., Man, G. C. W., Ding, Y., Wang, C. C., & Chung, J. P. W. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2022.11.004 · Cited by 13
Lei, A., Yang, Q., Cai, W., Liu, Y. F., Lan, Y., Qin, A., Hu, F. Y., & Zhou, J. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12429 · Cited by 13
Neumann, S., Shirley, S. A., Kemp, R. A., & Hook, S. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00537 · Cited by 14
Metadata
- Authors
- Talmadge, J. E., & Gabrilovich, D. I.
- Affiliations
- University of Nebraska Medical Center (US)
- The Wistar Institute (US)
- Corresponding author
- Talmadge, James E.
- Venue
- Nature Reviews Cancer
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 10
- Pages
- 739-752
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4358792
- OpenAlex
- W2122403898
- Cited by
- 1,148
- References
- 197
- Citations by year
- 2026: 29 · 2025: 57 · 2024: 80 · 2023: 74 · 2022: 105 · 2021: 132 · 2020: 110 · 2019: 95 · 2018: 101 · 2017: 90 · 2016: 129 · 2015: 93 · 2014: 43 · 2013: 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA084488, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- myeloid-derived suppressor cells, tumor microenvironment, T cell suppression, immune evasion, tumor progression, metastasis, multipotent progenitors
- MeSH terms
- Animals, Antigens, Differentiation, Antigens, Neoplasm, Cell Differentiation, Cell Biology, Hematopoiesis, Extramedullary, Humans, Leukemoid Reaction, Medical Oncology, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Chemokines, Cell Lineage, Tumor Escape, Hematopoietic Stem Cell Mobilization, Myeloid Cells, Myeloid Progenitor Cells, Multipotent Stem Cells, Tumor Burden, History, 20th Century, History, 21st Century, Mice, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.